Skip to main content
. 2002 Feb 16;324(7334):410–414. doi: 10.1136/bmj.324.7334.410

Figure.

Figure

Sequence of treatment for postmenopausal women with hormone receptor positive, metastatic breast cancer. Antioestrogens are tamoxifen or torimefene. Non-steroidal aromatase inhibitors are anastrozole and letrozole. When fulvesterant is available for routine clinical use, it will also be a second line treatment